Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Outpatient treatment of patients with keloid scars using intralesional triamcinolone
RBR-5gvsgpCompleted
- Sponsor
- UNIPAC
- Start
- Feb 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of triamcinolone acetonide in keloid, sponsored by UNIPAC. Primary endpoint: Patient profile and factors related to keloid formation. Started Feb 2010; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
keloid
Beyond the preview
Go deeper on RBR-5gvsgp.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5gvsgp.